| Code | 3210A | ||||||||||
| MA number | 83/0871/92-CS | ||||||||||
| Product Form: | tbl 50x5 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Upjohn EESV, Netherland | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 30.12.1992 |
| Pediatric posology: | Yes |
| SPC: |
SPC_Norvasc_tbl_10_2023.pdf
|
| PIL: |
PIL_Norvasc tablety_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 10.05.2018 |
